PKM2, as a key metabolic enzyme in TME, enters the soluble environment through secretion, regulates the dynamic balance of TME, affects the expression of cytokines and growth factors, and then promotes the proliferation, invasion, and angiogenesis of tumor cells. The gene discussed is PKM; the disease is neoplasm.